Stressor controllability and learned helplessness: The roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor

Amat, 1998, Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat, Brain Res., 812, 113, 10.1016/S0006-8993(98)00960-3 Bakshi, 2002, Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala, J. Neurosci., 22, 2926, 10.1523/JNEUROSCI.22-07-02926.2002 Bale, 2000, Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour are hyper-sensitive to stress, Nat. Genet., 24, 410, 10.1038/74263 Bland, 2003, Stressor controllability modulates stress-induced dopamine and serotonin efflux and morphine-induced serotonin efflux in the medial prefrontal cortex, Neuropsychopharmacology, 28, 1589, 10.1038/sj.npp.1300206 Braestrup, 1980, Urinary and brain B carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors, PNAS, 77, 2288, 10.1073/pnas.77.4.2288 Casanovas, 1996, Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways., J. Neurochem., 67, 1945, 10.1046/j.1471-4159.1996.67051945.x Celada, 2001, Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A GABAA, and glutamate receptors, J. Neurosci., 21, 9917, 10.1523/JNEUROSCI.21-24-09917.2001 Chalmers, 1995, Localization of novem corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression, J. Neurosci., 13, 6340, 10.1523/JNEUROSCI.15-10-06340.1995 Chen, 1996, Design and synthesis of a series of non-peptide high affinity human CRF receptor antagonists, J. Med. Chem., 39, 4358, 10.1021/jm960149e Commons, 2003, A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders, Neuropsychopharmacology, 28, 206, 10.1038/sj.npp.1300045 Coste, 2000, Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2, Nat. Genet., 24, 403, 10.1038/74255 Deak, 1999, The non-peptide corticotropin-releasing hormone antagonist antalarmin treats behavioral and endocrine responses to stress, Endocrinology, 140, 79, 10.1210/en.140.1.79 Dilts, 1995, Differential activation of the 5-hydroxytryptamine-containing neurons of the midbrain raphe of the rat in response to randomly presented inescapable sound, Neurosci. Lett., 199, 78, 10.1016/0304-3940(95)12027-2 Drugan, 1984, Librium prevents the analgesia and shuttlebox escape deficit typically observed following inescapable shock, Pharmacol. Biochem. Behav., 21, 749, 10.1016/S0091-3057(84)80014-3 Foa, 1992, Uncontrollability and impredictability in PTSD: an animal model, Psychol. Bull., 112, 218, 10.1037/0033-2909.112.2.218 Funk, 2003, Effect of blockade of corticotropin-releasing factor receptors in the median raphe nucleus on stress-induced c-fos mRNA in the rat brain, Neuroscience, 122, 1, 10.1016/j.neuroscience.2003.08.003 Gambarana, 2001, Animal models for the study of antidepressant activity, Brain Res. Protoc., 7, 11, 10.1016/S1385-299X(00)00056-8 Graeff, 1996, Role of S-NT in stress, anxiety and depression, Pharmacol. Biochem. Behav., 54, 129, 10.1016/0091-3057(95)02135-3 Grahn, 1999, Opioid-dependent effects of inescapable shock on escape behavior and conditioned fear responding are mediated by the dorsal raphe nucleus, Behav. Brain Res., 99, 153, 10.1016/S0166-4328(98)00101-6 Grahn, 1999, Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor, Brain Res., 826, 35, 10.1016/S0006-8993(99)01208-1 Grahn, 2002, Blockade of alpha-1 adrenoreceptors in the dorsal raphe nucleus prevents enhanced conditioned fear and impaired escape performance following uncontrollable stressor exposure in rats, Behav. Brain Res., 134, 387, 10.1016/S0166-4328(02)00061-X Grau, 1981, Long-term stress-induced analgesia and activation of the opiate system, Science, 213, 1409, 10.1126/science.7268445 Gray, 1992, Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat, Peptides, 13, 451, 10.1016/0196-9781(92)90074-D Grigoriadis, 1996, I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 receptors, Mol. Pharmacol., 50, 679 Hammack, 2002, The role of corticotropin releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress, J. Neurosci., 22, 1020, 10.1523/JNEUROSCI.22-03-01020.2002 Hammack, 2003, Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress, J. Neurosci., 23, 1020, 10.1523/JNEUROSCI.23-03-01019.2003 Hammack, S.E., Richey, K.J., Watkins, L.R., Maier, S.F., 2004. Chemical lesion of the bed nucleus of the stria terminalis blocks behavioral consequences of uncontrollable stress. Behav. Neurosci. 118, 443–448. Hammack, S.E., Pepin, J.l., DesMarteau, J.S., Watkins, L.R., Maier, S.F., in press. Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress. Behav. Br. Res. 147, 55–64. Heinrichs, 1997, Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior, Regul. Pept., 71, 15, 10.1016/S0167-0115(97)01005-7 Helmreich, 1999, The effect of psychological factors on stress-induced neuropeptide mRNA expression within the paraventricular nucleus of the hypothalamus, J. Neuroendocrinol., 11, 121, 10.1046/j.1365-2826.1999.00300.x Higelin, 2001, 125I-antisauoagine 230: a novel and specific high affinity radio legend for the characterization of CRF Type 2 receptors, Neuropharmacology, 40, 114, 10.1016/S0028-3908(00)00105-2 Ho, 2001, Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor, Mol. Brain Res., 89, 29, 10.1016/S0169-328X(01)00050-X Hopwood, 2001, Noradrenergic modulation of serotonin release in rat dorsal and median raphe nuclei via α1 and α2A adrenoceptors, Neuropharmacology, 41, 433, 10.1016/S0028-3908(01)00087-9 Jackson, 1978, Exposure to inescapable shock produces both activity and associative deficits in the rat, Learn. Motiv., 9, 69, 10.1016/0023-9690(78)90027-9 Kennett, 1987, Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action, Eur. J. Pharmacol., 138, 53, 10.1016/0014-2999(87)90336-0 Kirby, 1997, The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid, Brain Res., 760, 218, 10.1016/S0006-8993(97)00287-4 Kirby, 2000, Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nuclcus, Neuropsychopharmacology, 22, 148, 10.1016/S0893-133X(99)00093-7 Kishimoto, 2000, Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2, Nat. Genet., 24, 415, 10.1038/74271 Koob, 1993, The role of corticotropin-releasing factor in behavioural responses to stress, vol. 172 Le, 1999, Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress in rats, Neuropsychopharmacology, 21, 435, 10.1016/S0893-133X(99)00024-X Le, 2000, The role of corticotropin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats, Psychopharmacolgy, 150, 317, 10.1007/s002130000411 Le, 2002, The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol., J. Neurosci., 22, 7844, 10.1523/JNEUROSCI.22-18-07844.2002 Lewis, 2001, Identificaiton of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF-2 receptor, Proc. Natl Acad. Sci. USA, 98, 7570, 10.1073/pnas.121165198 Lowry, 2002, Functional subsets of serotonergic neurones: implications for control of the hypothalamic–pituitary–adrencal axis, J. Neuroendocrinol., 14, 1, 10.1046/j.1365-2826.2002.00861.x Lowry, 2000, In vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system, J. Neurosci., 20, 7728, 10.1523/JNEUROSCI.20-20-07728.2000 Maier, 1990, The role of fear in mediating the shuttle escape learning deficit produced by inescapable shock, J. Exp. Psychol. Anim. Behav. Process., 16, 137, 10.1037/0097-7403.16.2.137 Maier, 1976, Learned helplessness: theory and evidence, J. Exp. Psychol. Gen., 105, 3, 10.1037/0096-3445.105.1.3 Maier, 1998, Stressor controllability, anxiety, and serotonin, Cog. Ther. Res., 6, 595, 10.1023/A:1018794104325 Maier, 1998, Cytokines for psychologists: Implications of bi-directional immune-to-brain communication for understanding behavior, mood, and cognition, Psychological. Rev., 105, 83, 10.1037/0033-295X.105.1.83 Maier, 1969, Pavlovian fear conditioning and learned helplessness Maier, 1986, Stressor controllability and the pituitary-adrenal system, Behav. Neurosci., 100, 669, 10.1037/0735-7044.100.5.669 Maier, 1993, The role of the amygdala and dorsal raphe nucleus in mediating the behavioral consequences of inescapable shock, Behav. Neurosci., 107, 377, 10.1037/0735-7044.107.2.377 Maier, 1994, Chlordiazepoxide microinjected in the region of the dorsal raphe nucleus eliminates the interference with escape responding produced by inescapable shock whether administered before inescapable shock or escape testing, Behav. Neurosci., 108, 121, 10.1037/0735-7044.108.1.121 Maier, 1995, The dorsal raphe nucleus is a site of action mediating the behavioral effects of the benzodiazepine receptor inverse agonist DMCM, Behav. Neurosci., 106, 759, 10.1037/0735-7044.109.4.759 Maier, 1995, 8-OH-DPAT microinjected in the region of the dorsal raphe nucleus blocks and reverses the enhancement of fear conditioning and the interference with escape produced by exposure to inescapable shock, Behav. Neurosci., 109, 404, 10.1037/0735-7044.109.3.404 Malberg, 2003, Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment, Neuropsychopharmacology, 28, 1562, 10.1038/sj.npp.1300234 Mansbach, 1997, Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist, Eur. J. Pharmacol., 323, 21, 10.1016/S0014-2999(97)00025-3 Matos, 1996, Serotonin release in the dorsal raphe and ventral hippocampus: raphe control of somatodendritis and terminal 5-HT release, J. Neural. Transm., 103, 173, 10.1007/BF01292626 Millan, 2003, The neurobiology and control of anxious states, Prog. Neurobiol., 70, 83, 10.1016/S0301-0082(03)00087-X Overmeier, 1968, Interference with avoidance behavior: failure to avoid traumatic shock, J. Exp. Psychol., 78, 340, 10.1037/h0026365 Overmier, 1967, Effects of inescapable shock upon subsequent escape and avoidance learning, J. Comp. Physiol., 63, 28 Pelleymounter, 2002, Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress, J. Pharmacol. Exp. Ther., 302, 145, 10.1124/jpet.302.1.145 Petty, 1996, Serotonin dysfunction disorders: a behavioral neurochemistry perspective, J. Clin. Psychiat., 57, 11 Peyron, 1998, Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods, Neuroscience, 82, 443, 10.1016/S0306-4522(97)00268-6 Price, 2001, Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor, J. Neurosci., 21, 2833, 10.1523/JNEUROSCI.21-08-02833.2001 Price, 1998, Effects of corticotropin-releasing factor on brain serotonergic activity, Neuropsychopharmacology, 18, 492, 10.1016/S0893-133X(97)00197-8 Radulovic, 1999, Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2, J. Neurosci., 19, 5016, 10.1523/JNEUROSCI.19-12-05016.1999 Reyes, 2001, Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors, Proc. Natl Acad. Sci. USA, 98, 2843, 10.1073/pnas.051626398 Sakanaka, 1987, Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method, J. Comp. Neurol., 260, 256, 10.1002/cne.902600209 Seligman, 1967, Failure to escape traumatic shock, J. Exp. Psychol., 74, 1, 10.1037/h0024514 Shaham, 1998, CP-154, 526, a selective, non peptide antagonist of the corticotropin-releasing factor type 1 receptor attenuates stress-induced relapse to drug seeking of cocaine-and heroin-trained rats, Psychopharmacology, 137, 184, 10.1007/s002130050608 Short, 1993, Stressor controllability, social interaction, and benzodiazepine systems, Pharmacol. Biochem. Behav., 45, 827, 10.1016/0091-3057(93)90128-G Short, 2000, Uncontrollable stress induces both anxiety and downregulation of dorsal raphe 5-HTlA receptors in rats: both follow the same timecourse, Soc. Neurosci. Abstracts, 26, 2267 Siegel, 1988, Attributions for negative life events and depression: the role of perceived control, J. Pers. Soc. Psychol., 54, 316, 10.1037/0022-3514.54.2.316 Soubrie, 1986, The lesion of serotonergic neurons does not prevent antidepressant-induced reversal of escape failures produced by inescapable shocks in rats, Pharmacol. Biochem. Behav., 25, 1, 10.1016/0091-3057(86)90220-0 Sprouse, 1987, Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists, Synapse, 1, 3, 10.1002/syn.890010103 Sramek, 2002, Generalized anxiety disorder, Drugs, 62, 1634, 10.2165/00003495-200262110-00005 Sutton, 1997, Inescapable shock-induced potentiation of morphine analgesia, Behav. Neurosci., 111, 1105, 10.1037/0735-7044.111.5.1105 Swanson, 1983, Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study, Neuroendocrinology, 36, 165, 10.1159/000123454 Takahashi, 2001, Role of CRF1 and CRF2 receptors in fear and anxiety, Neurosci. Biobehav. Rev., 25, 627, 10.1016/S0149-7634(01)00046-X Takemori, 2001, Involvement of CRH stubtype 1 receptor in the acquisition phase of learned helplessness in rats, Life Sci., 69, 1241, 10.1016/S0024-3205(01)01217-6 Tao, 2002, Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system, J. Pharmacol. Exp. Ther., 303, 1, 10.1124/jpet.102.037861 Tao, 1996, Differential regulation of 5-hydroxytryptamine release by GABAA and GABAB receptors in midbrain raphe nuclei and forebrain of rats, Brain J. Pharmacol., 119, 1375, 10.1111/j.1476-5381.1996.tb16049.x Vale, 1981, Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin, Science, 213, 1394, 10.1126/science.6267699 Valentino, 2001, Evidence for regional heterogeneity in CRH interactions in the dorsal raphe nucleus, J. Comp. Neurol., 435, 450, 10.1002/cne.1043 Van Der Linden, 2000, The efficacy of SSRI for social anxiety disorder: a meta-analysis of randomised controlled trials, Int. J. Clin. Psychopharmacol., 15, 515, 10.1097/00004850-200008002-00004 Van Oekelen, 2003, 5-HT2A AND 5-HT2C receptors and their atypical regulation properties, Life Sci., 72, 2429, 10.1016/S0024-3205(03)00141-3 Vertes, 1991, APHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat, J. Comp. Neurol., 313, 643, 10.1002/cne.903130409 Walker, 2003, Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety, Eur. J. Pharmacol., 463, 199, 10.1016/S0014-2999(03)01282-2 Weiss, 1968, Effects of coping responses on stress, J. Comp. Physiol., 65, 251 Weiss, 1986, Depression in an animal model: focus on the locus coerules, 191 Weiss, 1981, Behavioral depression produced by an uncontrollable stressor: relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain, Brain Res. Rev., 3, 36, 10.1016/0165-0173(81)90005-9 Will, 1998, Uncontrollable stressors potentiate the rewarding properties of morphine, Pharmacol. Biochem. Behav., 60, 655, 10.1016/S0091-3057(98)00027-6 Will, 2002, Modulation of the locomotor properties of morphine and amphetamine by uncontrollable stress, Pharmacol. Biochem. Behav., 71, 353, 10.1016/S0091-3057(01)00719-5 Will, M.J., Der-Avakian, A., Bland, S.T., Grahn, R.E., Hammack, S.E., Sparks, P.D., Pepin, J.L., Watkins, L.R., Maier, S.F., in press. Electrolytic lesions and pharmacological inhibition of the dorsal raphe nucleus prevent stressor potentiation of morphine conditioned place preference. Psychopharmacology. 2003, 141, 191–198. Woodmansee, 1993, Factors that modulate inescapable shock-induced reductions in daily activity in the rat, Pharmacol. Biochem. Behav., 45, 553, 10.1016/0091-3057(93)90505-N